These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38203212)

  • 1. Parasite DNA and Markers of Decreased Immune Activation Associate Prospectively with Cardiac Functional Decline over 10 Years among
    Sunderraj A; Cunha LM; Avila M; Alexandria S; Ferreira AM; de Oliveira-da Silva LC; Ribeiro ALP; Nunes MDCP; Sabino EC; Landay A; Kalil J; Chevillard C; Cunha-Neto E; Feinstein MJ
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards the establishment of a consensus real-time qPCR to monitor Trypanosoma cruzi parasitemia in patients with chronic Chagas disease cardiomyopathy: a substudy from the BENEFIT trial.
    Moreira OC; Ramírez JD; Velázquez E; Melo MF; Lima-Ferreira C; Guhl F; Sosa-Estani S; Marin-Neto JA; Morillo CA; Britto C
    Acta Trop; 2013 Jan; 125(1):23-31. PubMed ID: 22982466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in
    Gibaldi D; Vilar-Pereira G; Pereira IR; Silva AA; Barrios LC; Ramos IP; Mata Dos Santos HA; Gazzinelli R; Lannes-Vieira J
    Front Immunol; 2020; 11():306. PubMed ID: 32194558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients.
    Zrein M; Granjon E; Gueyffier L; Caillaudeau J; Liehl P; Pottel H; Cardoso CS; Oliveira CDL; de Oliveira LC; Lee TH; Ferreira AM; Ribeiro ALP; Busch MP; Sabino EC
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006226. PubMed ID: 29425201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human infectiousness and parasite load in chronic patients seropositive for Trypanosoma cruzi in a rural area of the Argentine Chaco.
    Macchiaverna NP; Enriquez GF; Bua J; Fernández MP; Sartor PA; Gürtler RE; Cardinal MV
    Infect Genet Evol; 2020 Mar; 78():104062. PubMed ID: 31683004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ten-year incidence of Chagas cardiomyopathy among asymptomatic Trypanosoma cruzi-seropositive former blood donors.
    Sabino EC; Ribeiro AL; Salemi VM; Di Lorenzo Oliveira C; Antunes AP; Menezes MM; Ianni BM; Nastari L; Fernandes F; Patavino GM; Sachdev V; Capuani L; de Almeida-Neto C; Carrick DM; Wright D; Kavounis K; Goncalez TT; Carneiro-Proietti AB; Custer B; Busch MP; Murphy EL;
    Circulation; 2013 Mar; 127(10):1105-15. PubMed ID: 23393012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parasitemia Levels in Trypanosoma cruzi Infection in Spain, an Area Where the Disease Is Not Endemic: Trends by Different Molecular Approaches.
    Flores-Chavez MD; Abras A; Ballart C; Ibáñez-Perez I; Perez-Gordillo P; Gállego M; Muñoz C; Moure Z; Sulleiro E; Nieto J; García Diez E; Simón L; Cruz I; Picado A
    Microbiol Spectr; 2022 Oct; 10(5):e0262822. PubMed ID: 36190410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Specific
    Gomes Dos Santos A; Watanabe EH; Ferreira DT; Oliveira J; Nakanishi ÉS; Oliveira CS; Bocchi E; Novaes CTG; Cruz F; Carvalho NB; Sato PK; Yamashiro-Kanashiro EH; Pontillo A; de Freitas VLT; Onuchic LF; Shikanai-Yasuda MA
    Front Immunol; 2020; 11():521409. PubMed ID: 33193300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chagas disease and liver transplantation: Experience in Argentina using real-time quantitative PCR for early detection and treatment.
    Balderramo D; Bonisconti F; Alcaraz A; Giordano E; Sánchez A; Barrabino M; Caeiro JP; Alvarellos T; Maraschio M
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28941300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease.
    Choudhuri S; Garg NJ
    mBio; 2020 Nov; 11(6):. PubMed ID: 33172999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different Transcriptomic Response to
    Oliveira TGM; Venturini G; Alvim JM; Feijó LL; Dinardo CL; Sabino EC; Seidman JG; Seidman CE; Krieger JE; Pereira AC
    Front Cell Infect Microbiol; 2022; 12():904747. PubMed ID: 35873155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Trypanosoma cruzi DNA in blood by PCR is associated with Chagas cardiomyopathy and disease severity.
    Sabino EC; Ribeiro AL; Lee TH; Oliveira CL; Carneiro-Proietti AB; Antunes AP; Menezes MM; Ianni BM; Salemi VM; Nastari L; Fernandes F; Sachdev V; Carrick DM; Deng X; Wright D; Gonçalez TT; Murphy EL; Custer B; Busch MP;
    Eur J Heart Fail; 2015 Apr; 17(4):416-23. PubMed ID: 25678239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence and Predictors of Progression to Chagas Cardiomyopathy: Long-Term Follow-Up of
    Nunes MCP; Buss LF; Silva JLP; Martins LNA; Oliveira CDL; Cardoso CS; Brito BOF; Ferreira AM; Oliveira LC; Bierrenbach AL; Fernandes F; Busch MP; Hotta VT; Martinelli LMB; Soeiro MCFA; Brentegani A; Salemi VMC; Menezes MM; Ribeiro ALP; Sabino EC
    Circulation; 2021 Nov; 144(19):1553-1566. PubMed ID: 34565171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
    Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
    Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-1 Prevents Infection and Damage Induced by Trypanosoma cruzi on Cardiac Cells.
    Benatar AF; García GA; Bua J; Cerliani JP; Postan M; Tasso LM; Scaglione J; Stupirski JC; Toscano MA; Rabinovich GA; Gómez KA
    PLoS Negl Trop Dis; 2015; 9(10):e0004148. PubMed ID: 26451839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed Cell Death Protein 1-PDL1 Interaction Prevents Heart Damage in Chronic
    Fonseca R; Salgado RM; Borges da Silva H; do Nascimento RS; D'Império-Lima MR; Alvarez JM
    Front Immunol; 2018; 9():997. PubMed ID: 29867974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of Human CD11b
    Passos LSA; Magalhães LMD; Soares RP; Marques AF; Alves MLR; Giunchetti RC; Nunes MDCP; Gollob KJ; Dutra WO
    Front Immunol; 2018; 9():3015. PubMed ID: 30662439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins change the cytokine profile in
    González-Herrera F; Clayton NS; Guzmán-Rivera D; Carrillo I; Castillo C; Catalán M; Anfossi R; Quintero-Pertuz H; Quilaqueo ME; Olea-Azar C; Rivera-Meza M; Kemmerling U; Ridley AJ; Vivar R; Maya JD
    Front Immunol; 2022; 13():1035589. PubMed ID: 36713380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed Activation of T Cells at the Site of Infection Facilitates the Establishment of Trypanosoma cruzi in Both Naive and Immune Hosts.
    Padilla AM; Rosenberg C; Cook P; Sanchez-Valdez F; McElhannon C; Tarleton RL
    mSphere; 2023 Feb; 8(1):e0060122. PubMed ID: 36695605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection.
    Cetron MS; Basilio FP; Moraes AP; Sousa AQ; Paes JN; Kahn SJ; Wener MH; Van Voorhis WC
    Am J Trop Med Hyg; 1993 Sep; 49(3):370-82. PubMed ID: 8372959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.